![Derrell Porter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 101 175 $ al 31/08/2026
Dr. Derrell D.
Porter is an Independent Director at Acumen Pharmaceuticals, Inc., an Independent Director at Passage Bio, Inc. and a Chief Executive Officer & Director at CTRL Therapeutics, Inc. He is on the Board of Directors at Acumen Pharmaceuticals, Inc., Passage Bio, Inc., CTRL Therapeutics, Inc. and Biosortia Pharmaceuticals, Inc. Dr. Porter was previously employed as a Chief Executive Officer by Cellevolve Bio, Inc., a Senior Vice President & Global Head-Commercial by Atara Biotherapeutics, Inc., a Vice President by Gilead Sciences, Inc., a Sales Manager & Director-Corporate Development by AbbVie, Inc., and a Director-Corporate Development & Sales Manager by Amgen, Inc. He also served on the board at Alliance for Regenerative Medicine and Portal Innovations LLC.
He received his undergraduate degree from the University of California, Los Angeles, an MBA from The Wharton School of the University of Pennsylvania and a doctorate degree from Perelman School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/06/2026 | 35.500 ( 0,05 % ) | 101 175 $ | 31/08/2026 | |
PASSAGE BIO, INC. -.--% | 19/05/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PASSAGE BIO, INC. | Director/Miembro de la Junta | 27/05/2021 |
| ACUMEN PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 04/01/2023 |
Biosortia Pharmaceuticals, Inc.
 Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of algal technologies with focus on concentration, dewatering, drying and extraction of biomass | Director/Miembro de la Junta | - |
CTRL Therapeutics, Inc.
 CTRL Therapeutics, Inc. BiotechnologyHealth Technology Develops liquid biopsy platform that isolates circulating tumor cells from blood | Director Ejecutivo | 01/11/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Cellevolve Bio
 Cellevolve Bio Pharmaceuticals: MajorHealth Technology Develops and commercializes cell therapies | Director Ejecutivo | 01/11/2023 |
| ATARA BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2019 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/05/2017 |
Portal Innovations LLC
 Portal Innovations LLC Investment ManagersFinance Portal Innovations invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medtech and bioinformatics. It provides financing for seed and early stage capital requirements. | Director/Miembro de la Junta | - |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 14 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Acumen Pharmaceuticals, Inc.
 Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
Biosortia Pharmaceuticals, Inc.
Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of algal technologies with focus on concentration, dewatering, drying and extraction of biomass | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perelman School of Medicine
 Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
CTRL Therapeutics, Inc.
CTRL Therapeutics, Inc. BiotechnologyHealth Technology Develops liquid biopsy platform that isolates circulating tumor cells from blood | Health Technology |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medtech and bioinformatics. It provides financing for seed and early stage capital requirements. | Finance |
Cellevolve Bio
Cellevolve Bio Pharmaceuticals: MajorHealth Technology Develops and commercializes cell therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
